Back to Melanotan-ii research
melanotan-ii melanocortin agonist other 2026-04-03 PubMed

Exploring the Hidden World of Illicit Melanotan Use Online

A glimpse into the underground market of melanotan.

Background

The synthetic peptides Melanotan-I and Melanotan-II are analogues of alpha-melanocyte stimulating hormone (a-MSH), a natural hormone that stimulates melanin production. These substances are widely available through unregulated online markets and are subcutaneously injected by individuals seeking a cosmetic tan. Despite their increasing prevalence, there is a significant lack of research and understanding regarding the motivations, acquisition methods, and user experiences associated with these illicit tanning agents.

Results

The survey qualitatively explored various aspects of illicit melanotan use, indicating that cosmetic enhancement was a primary driver for users, often despite potential safety concerns. Participants provided insights into the ease of purchasing Melanotan-I and Melanotan-II through underground online channels, suggesting high accessibility. > The study revealed a significant user base willing to engage with unregulated substances for aesthetic purposes, highlighting a critical gap in public health awareness and regulatory oversight. While specific quantitative data (e.g., percentages of users reporting certain motivations or side effects) were not provided in the abstract, the findings underscored a consistent demand for these peptides. The abstract indicated that users often planned for continued use, suggesting a pattern of long-term engagement with these illicit tanning agents.

Why It Matters

This study provides crucial initial insights into the largely unexamined landscape of illicit melanotan use, underscoring significant public health concerns related to unregulated substances. Understanding user motivations and acquisition methods is vital for developing targeted harm reduction strategies and public awareness campaigns. The findings suggest an urgent need for regulatory bodies and healthcare providers to address the risks associated with unregulated peptide use and to inform the public about safer alternatives. Future research should include larger, quantitative studies and potentially clinical observations to fully characterize the health impacts and prevalence of these substances.


melanotan-ii melanocortin agonist protocol relevant safety data present
Source: pubmed:30142729 · Ingested 2026-04-03 · Digest: gemini-2.5-flash